HHAA
AGN

Henry H. Armstrong Associates’s Allergan Inc AGN Stock Holding History

Henry H. Armstrong Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,690
Closed -$882K – 54
2017
Q1 		$882K Hold
3,690
– – 0.17% 33
2016
Q4 		$775K Hold
3,690
– – 0.16% 32
2016
Q3 		$850K Hold
3,690
– – 0.16% 31
2016
Q2 		$853K Buy
3,690
+1,100
+42% +$254K 0.17% 31
2016
Q1 		$694K Buy
2,590
+90
+4% +$24.1K 0.14% 30
2015
Q4 		$781K Buy
+2,500
New +$781K 0.15% 31

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $815M AUM 30.42% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
MA
Marshwinds Advisory St Simons Island, Georgia $187M AUM 1.79% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Henry H. Armstrong Associates's AGN Position: Q2 2017 in Review

Henry H. Armstrong Associates sold out of Allergan Inc (AGN) in Q2 2017, closing a stake of 3,690 shares — an estimated $882K sold.

Henry H. Armstrong Associates first reported a position in AGN in Q4 2015 and held it in 6 quarters. The position peaked at $882K in Q1 2017. 13 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Henry H. Armstrong Associates reported no remaining Allergan Inc position as of Q2 2017 after selling out during the quarter.
  • Henry H. Armstrong Associates sold 3,690 Allergan Inc shares in Q2 2017, an estimated $882K.
  • Henry H. Armstrong Associates first reported a position in Allergan Inc in Q4 2015 and held it in 6 quarters.
  • Henry H. Armstrong Associates's Allergan Inc position peaked at $882K in Q1 2017.
  • 13 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2017.

Based on Henry H. Armstrong Associates's 13F filing for Q2 2017, filed 26 Jul 2017.